Tower Research Capital LLC (TRC) - ZYNERBA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,588
-30.4%
2,814
-82.2%
0.00%
Q2 2023$5,15615,817
+18729.8%
0.00%
Q1 2023$0
-100.0%
84
-99.4%
0.00%
Q4 2022$8
-100.0%
15,033
-48.4%
0.00%
Q3 2022$21,000
+950.0%
29,146
+1280.0%
0.00%
Q2 2022$2,000
-50.0%
2,112
+17.2%
0.00%
Q1 2022$4,0001,802
+2368.5%
0.00%
Q4 2021$0
-100.0%
73
-99.7%
0.00%
-100.0%
Q2 2021$122,000
+481.0%
23,194
+273.3%
0.00%
+200.0%
Q2 2020$21,000
-19.2%
6,213
+46.2%
0.00%
-50.0%
Q4 2019$26,000
-38.1%
4,250
-23.4%
0.00%
-33.3%
Q3 2019$42,000
-41.7%
5,548
+4.9%
0.00%
-40.0%
Q2 2019$72,000
+105.7%
5,287
-54.0%
0.01%
+66.7%
Q4 2018$35,000
+775.0%
11,497
+2199.4%
0.00%
Q3 2018$4,000
-85.7%
500
-82.3%
0.00%
-100.0%
Q2 2018$28,000
-54.1%
2,825
-59.7%
0.00%
-60.0%
Q1 2018$61,000
+84.8%
7,014
+79.2%
0.01%
+66.7%
Q3 2017$33,000
+3200.0%
3,913
+4503.5%
0.00%
Q2 2017$1,000
-50.0%
85
-15.0%
0.00%
Q1 2017$2,0000.0%100
-55.4%
0.00%
Q2 2016$2,000
+100.0%
224
+261.3%
0.00%
Q4 2015$1,000
-66.7%
62
-69.0%
0.00%
Q3 2015$3,0002000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 2,679,457$20,257,0000.73%
Portolan Capital Management 777,293$5,876,0000.66%
CAMPBELL CAPITAL MANAGEMENT INC 110,451$835,0000.62%
ZEKE CAPITAL ADVISORS, LLC 402,212$3,041,0000.27%
Leap Investments LP 46,084$348,0000.17%
Bernardo Wealth Planning LLC 26,419$199,0000.14%
Claraphi Advisory Network, LLC 14,744$111,0000.07%
Sterling Investment Advisors, Ltd. 11,000$83,0000.04%
A.R.T. Advisors, LLC 81,372$615,0000.03%
Mirae Asset Global Investments Co., Ltd. 544,408$4,116,0000.03%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders